2 unknown. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 2 | Unknown 2 |
Follow Supranuclear Palsy, Progressive: new trials by email Literature Review of Supranuclear Palsy, Progressive trials Research Report on Supranuclear Palsy, Progressive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Tolfenamic Acid in Individuals With PSP at 12-Weeks Tolfenamic Acid, Placebos - Progressive Supranuclear Palsy | Phase 1 / Phase 2 | Unknown | NeuroTau, Inc. | 24 | 2021-01-01 | 2020-02-05 |
| Clinical Trial to Evaluate Bone Marrow Stem Cell Therapy for PSP, a Rare Form of Parkinsonism stem cell therapy - Progressive Supranuclear Palsy | Phase 1 / Phase 2 | Unknown | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 25 | 2012-12-01 | 2013-04-04 |
Basal Ganglia Diseases (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Cranial Nerve Diseases (2) · Eye Diseases (2) · Movement Disorders (2) · Nervous System Diseases (2) · Neurodegenerative Diseases (2) · Neurologic Manifestations (2) · Ocular Motility Disorders (2) · Ophthalmoplegia (2) · Paralysis (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Tauopathies (2)
tolfenamic acid (1)
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1) · NeuroTau, Inc. (1)
Italy (1) · United States (1)
Marwan Sabbagh, MD (1) · Nasser Zawia, PhD (1) · Rosaria Giordano, MD (1)